Eric Racine Joins National Health Council Board of Directors


Eric Racine Board Announcement (PDF)

(WASHINGTON, DC, May 31, 2022) At its March meeting, the National Health Council (NHC) Board of Directors unanimously added Eric Racine, PharmD, MBA, Vice President & Head, US Public Affairs & Patient Advocacy at Sanofi.

“As we work to implement the NHC’s new strategic plan, Eric will provide valuable input and guidance as a new member of the Board,” said LaVarne Burton, President & Chief Executive Officer, American Kidney Fund, and the Chairperson of the 2022 NHC Board of Directors. “I, and the other members of the NHC Board, welcome and look forward to collaborating with Eric.”

“I am excited and honored to have Eric join the NHC Board,” said Randall Rutta, Chief Executive Officer of the NHC. “Eric is a true champion for patient engagement and has been contributing to advance the NHC’s patient-centered priorities. His critical expertise during challenging times will directly enhance our advocacy for people with chronic diseases and disabilities.”

Racine is filling the open seat left vacant by Tanisha Carino formerly of Alexion Pharmaceuticals, Inc. His appointment runs through the end of 2022.

# # #

Created by and for patient organizations more than 100 years ago, the National Health Council (NHC) brings diverse organizations together to forge consensus and drive patient-centered health policy. We promote increased access to affordable, high-value, sustainable health care. Made up of more than 145 national health- related organizations and businesses, the NHC’s core membership includes the nation’s leading patient organizations. Other members include health-related associations and nonprofit organizations including the provider, research, and family caregiver communities; and businesses representing biopharmaceutical, device, diagnostic, generic drug, and payer organizations. Learn more at: